COURSE INFORMATION

Course Description

The challenge we face as health care professionals is keeping current on the latest developments in HIV clinical care, especially issues regarding co-infections with hepatitis B and/or C.

The HIV Update course is a comprehensive continuing medical education program specifically designed to foster the integration of all aspects of HIV care. The HIV epidemic has become more multifaceted, such that the care of today’s HIV-infected patient may involve management of non-AIDS-defining malignancies, reproductive issues and renal, endocrine and liver diseases, as well as ensuring adherence to lifelong antiretroviral therapy.

Our outstanding faculty, recognized as leaders in clinical practice and medical education, will challenge, refresh and enrich your knowledge in all fields of HIV management. Course material will be presented in a distraction-free environment through multimedia formats that include:

  • State-of-the-art lectures
  • Case-based workshops
  • Interactive sessions with the Audience Response System, a learning tool that lets you anonymously test your knowledge by answering questions highlighting important diagnostic and therapeutic issues
  • Question and answer sessions with faculty to address challenging cases or ask your pressing questions

This will be a critical, well-informed, clinically relevant course.

Learning Objectives

At the end of this course, you will be able to:

  1. Evaluate current data on pre-exposure prophylaxis to prevent HIV infection.
  2. Analyze the clinical manifestations of HIV disease
  3. Integrate into practice the evolving advances in HIV care, including antiretroviral therapy tailoring to genotype and phenotype, appropriate incorporation of newer antiretroviral agents, approach to initial treatment and salvage antiretroviral therapy, management of challenging
    populations and appropriate management of common
    infections, opportunistic and otherwise.
  4. Educate HIV-infected patients regarding antiretroviral therapy adherence and potential long-term complications such as the risk for development of specific malignancies, chronic liver disease and chronic metabolic issues.
  5. Incorporate treatment approaches to address co-morbidities and infectious complications.
  6. Determine which HIV-infected patients with hepatitis C virus (HCV) infection are candidates for HCV treatment with directly acting antivirals, design regimens and assessments of response and describe drug drug interactions, especially in HIV/HCV co-infected patients on antiretroviral therapy.